Global Vaccine Action Plan. Decade of vaccine collaboration
Vaccine 31 Suppl. 2: B5-31
2013
ISSN/ISBN: 1873-2518 PMID: 23734366 DOI: 10.1016/j.vaccine.2013.02.015Document Number: 566909
Document emailed within 0-6 h
Related Documents
2013: Global Vaccine Action Plan. Decade of vaccine collaboration Vaccine 31 Suppl. 2: B5-31Thacker, N.; Vashishtha, V.M.; Awunyo-Akaba, J.; Mistry, R.Farhad. 2013: Civil society organizations, the implementing partners of the Global Vaccine Action Plan Vaccine 31 Suppl. 2: B97-102
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Kronander, U.N.öm.; Nilsson, L. 2009: Egg allergy and vaccine against the new influenza. a plan of action in Ostergotland Lakartidningen 106(48): 3230
Ford, A.Q.; Touchette, N.; Hall, B.Fenton.; Hwang, A.; Hombach, J. 2016: Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery Vaccine 34(13): 1489-1495
LaForce, F.M. 2011: Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: a success story and a window into the future Vaccine 29(Suppl 1): A1
Shahzad, A.; Köhler, G. 2009: Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program Vaccine 27(39): 5293-5294
Leonardi, M.; Martelletti, P.; Burstein, R.; Fornari, A.; Grazzi, L.; Guekht, A.; Lipton, R.B.; Mitsikostas, D.D.; Olesen, J.; Owolabi, M.O.; Ruiz De la Torre, E.; Sacco, S.; Steiner, T.J.; Surya, N.; Takeshima, T.; Tassorelli, C.; Wang, S.-J.; Wijeratne, T.; Yu, S.; Raggi, A. 2024: The World Health Organization Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders Journal of Headache and Pain 25(1): 4
Elias, C. 2011: The Decade of Vaccines Collaboration: developing a global roadmap for saving lives Expert Review of Vaccines 10(11): 1493-1495
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
De Silva, A.M.; Harris, E. 2018: Which Dengue Vaccine Approach Is the Most Promising, and Should we be Concerned about Enhanced Disease after Vaccination? the Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials Cold Spring Harbor Perspectives in Biology 10(6)
Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Townsend, J.S.; Steele, C.Brooke.; Hayes, N.; Bhatt, A.; Moore, A.R. 2017: Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program Journal of Women's Health 26(3): 200-206
Francis, D.P. 1995: The public's health unprotected. Reversing a decade of underutilization of hepatitis B vaccine JAMA 274(15): 1242-1243
Nelson, E.A.S.; Bloom, D.E.; Mahoney, R.T. 2014: Monitoring what governments "give for" and "spend on" vaccine procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline Plos one 9(2): E89593
Nelson, E.A.S.; Bloom, D.E.; Mahoney, R.T. 2014: Monitoring what governments "give for" and "spend on" vaccine procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline Plos one 9(2): E89593
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Marzetta, C.A.; Lee, S.S.; Wrobel, S.J.; Singh, K.J.; Russell, N.; Esparza, J.é 2010: The potential global market size and public health value of an HIV-1 vaccine in a complex global market Vaccine 28(30): 4786-4797